For example, GLTSCR1 polymorphisms were associated with the aggressiveness of lung cancer and the progression of oligodendroglioma [2], and the high expression of GLTSCR1 predicted a poor prognosis for prostate cancer [3]. This evidence concerns the gene BICRA and prostate carcinoma.